Search results

  1. ME/CFS Science Blog

    Muscle sodium content in patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome 2022, Petter, Scheibenbogen, Wirth et al

    Looks like the VADYS-ME study found something similar: https://s4me.info/threads/investigations-of-vascular-dysfunction-and-hypoperfusion-in-patients-diagnosed-with-me-cfs-vadys-me-2027-d%C3%B6hner-et-al.51494/post-716581
  2. ME/CFS Science Blog

    The buspirone challenge test clearly distinguishes ME/CFS patients from healthy controls: why is it not being developed and deployed?

    I wrote a brief blog article on the buspirone findings to help highlight the findings. It links to this S4ME discussion and the excellent overview by forestglip. https://mecfsscience.org/increased-prolactin-response-to-buspirone/
  3. ME/CFS Science Blog

    Anil van der Zee has been appointed a Knight of the Order of Orange-Nassau

    Well-deserved recognition for an impressive person.
  4. ME/CFS Science Blog

    The buspirone challenge test clearly distinguishes ME/CFS patients from healthy controls: why is it not being developed and deployed?

    Excellent work! The group tags probably aren't that important. The main thing to note is that several studies were students from working under Behan as your review already does.
  5. ME/CFS Science Blog

    Netherlands: PAIS [Post-Acute Infection Syndromes] Conference, 26th to 29th August, 2026, Amsterdam

    Too poor to buy online access to the conference but would be interested in hearing more about this presentation:
  6. ME/CFS Science Blog

    Thesis Hypothalamic Dysfunction and Neurotransmitter Abnormalities in the Postviral Fatigue Syndrome, 1992, Bakheit

    I calculated an effect size (Hedges g) using the data in the thesis. Males Using prolactin values after 1 hour -1.38 [-2.42, -0.30] Using prolactin difference between baseline and 1 hour - 1.45 [-2.51, -0.36] Females Using prolactin values after 1 hour -1.71 [-2.96, -0.40] Using prolactin...
  7. ME/CFS Science Blog

    The buspirone challenge test clearly distinguishes ME/CFS patients from healthy controls: why is it not being developed and deployed?

    Yes that might be the more conservative option. The plot does show 15-minute intervals before the administration of buspirone. And as ScoutB says, the growth hormone plot also shows the same intervals up unto 240 so perhaps it's simply a bad description in the methods section.
  8. ME/CFS Science Blog

    The buspirone challenge test clearly distinguishes ME/CFS patients from healthy controls: why is it not being developed and deployed?

    I've been extracting the data from the graphs in the buspirone studies, it looks something like this. For Bakheit 1992 I took males only, Sharpe 1996 is also males only, the other studies have both sexes combined. EDIT: there might be an error in the Sharpe 1996 original data plot, see the...
  9. ME/CFS Science Blog

    The buspirone challenge test clearly distinguishes ME/CFS patients from healthy controls: why is it not being developed and deployed?

    I think the Sharpe 1996 (Cowen group) study had a pretty good view on the problem saying it was likely the dopamine instead of serotonin pathway that was abnormal. They wrote: Increased prolactin response to buspirone in chronic fatigue syndrome - PubMed My guess is that buspirone was seen as...
  10. ME/CFS Science Blog

    The buspirone challenge test clearly distinguishes ME/CFS patients from healthy controls: why is it not being developed and deployed?

    I have the CIBA symposium book from 1993 but it doesn't have much discussion on the buspirone tests. Doesn't work to upload the doc but here are some screenshot of the places where buspirone or prolactin is mentioned, the discussion moves to other topic afterwards. First section: Then a bit...
  11. ME/CFS Science Blog

    The buspirone challenge test clearly distinguishes ME/CFS patients from healthy controls: why is it not being developed and deployed?

    Yeah maybe the dopamine system in ME/CFS is less responsive so that those natural stimuli that reduce it centrally have less impact and thus we see a blunted prolactin response. But when you don't impact the dopamine system itself but simply block the dopamine that's already there, we see an...
  12. ME/CFS Science Blog

    The buspirone challenge test clearly distinguishes ME/CFS patients from healthy controls: why is it not being developed and deployed?

    There are a couple of studies that tried to block the serotonin route of buspirone and measure what effect it had on its prolactin effect. This 2001 study found that approximately 50% of its effect on prolactin disappeared when participants are first given the 5-HT1A antagonist pindolol. So...
  13. ME/CFS Science Blog

    The buspirone challenge test clearly distinguishes ME/CFS patients from healthy controls: why is it not being developed and deployed?

    Your little review was probably the most interesting paper I read on ME/CFS in 2026! Hope you can rest well and recover.
  14. ME/CFS Science Blog

    The buspirone challenge test clearly distinguishes ME/CFS patients from healthy controls: why is it not being developed and deployed?

    Thanks, updated. There may be other errors because I didn't double-check. The 'effect size' are based on simply eyeballing the graphs and dividing the peak by the baseline value regardless at which hour the peak was. If the plan is to publish in a journal, one could perhaps use software to...
  15. ME/CFS Science Blog

    The buspirone challenge test clearly distinguishes ME/CFS patients from healthy controls: why is it not being developed and deployed?

    Some thoughts about the cause and mechanism The normal prolactin response after mCPP (and some dl-fenfluramine studies), and attenuated response after exercise and the insulin stress test suggests that there isn't some mechanism at play that simply shows increased prolactin responses in ME/CFS...
  16. ME/CFS Science Blog

    The buspirone challenge test clearly distinguishes ME/CFS patients from healthy controls: why is it not being developed and deployed?

    Limitations After reading the studies, one big limitation is that they were all quite small: almost all studies have less than 30 ME/CFS patients. The prolactine results also show a lot of variability in the results and there are multiple factors that might influence it (sex, menstruation...
  17. ME/CFS Science Blog

    The buspirone challenge test clearly distinguishes ME/CFS patients from healthy controls: why is it not being developed and deployed?

    Am re-reading the studies anyway, so here's an example of the table I had in mind: StudyPatients - controlsStimulantEffect on prolactinNotes Bakheit 1992 (Behan group)15 post-viral fatigue syndrome patients 40% female 13 healthy controls 13 depressed controls60 mg buspironeSimilar...
  18. ME/CFS Science Blog

    Immunological Patient Stratification in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome 2024 Rohrhofer et al

    Thanks for highlighting this. ECP = eosinophil cationic protein EDN = eosinophil-derived neurotoxin So these are eosinophil proteins that they assume would also be increased in case of chronic mast cell activation.
  19. ME/CFS Science Blog

    The buspirone challenge test clearly distinguishes ME/CFS patients from healthy controls: why is it not being developed and deployed?

    Impressive work @forestglip, thanks for digging into this! Small suggestion for your summary: it would be useful to have a table of the ME/CFS studies with the number of participants they used (male/female), the type stimulant and dosage used and possibly info about the effect size.
Back
Top Bottom